Trial examines hydroxychloroquine’s ability to ward off infections in people exposed to the virus.

Examining resected tumors reveals a lung microbiota signature associated with a poor prognosis.

The host–microbe relationship plays a key role in this stubborn infection.

Dozens of trials explore a wide variety of drug strategies and tumor types.

Trial provides new options for bacillus Calmette-Guérin–unresponsive non-muscle invasive type.

These phase 2 trials provide new options for treating glioblastomas and meningiomas.

Four promising projects aim to discover which patients will experience benefits or toxicity.

Researchers are investigating dramatic hormonal changes that occur days after bariatric surgery.

Cross-disciplinary researchers collaborate at the Judith and Stewart Colton Center for Autoimmunity.

New research in diabetes, obesity, and metabolic disease focuses on improving treatment.